EquityZen Growth Technology Fund LLC - Series 172
Raised
$450K
Investors
24
Min Invest
$9,526
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 172 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC on January 4, 2018. The entity raised $450,000 from 24 investors under Rule 506(b) and 3(c)(1) exemptions, with a $10,000 minimum investment. This is one of approximately 150 related entities within the EquityZen private equity platform.
This offering represents a typical SPV structure in the private equity secondaries market, using 506(b) private placement and 3(c)(1) Investment Company Act exemptions. The $10,000 minimum investment is significantly lower than traditional institutional private equity vehicles, reflecting a platform model designed for accredited individual investors accessing pre-IPO company shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Erin Rosenthal
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
